Log in to save to my catalogue

488 From discovery to the clinical laboratory: a methodological appraisal of untargeted metabolomics...

488 From discovery to the clinical laboratory: a methodological appraisal of untargeted metabolomics...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1c4844a321340c3986bae0e83fe5945

488 From discovery to the clinical laboratory: a methodological appraisal of untargeted metabolomics platforms to characterize inborn errors of metabolism

About this item

Full title

488 From discovery to the clinical laboratory: a methodological appraisal of untargeted metabolomics platforms to characterize inborn errors of metabolism

Publisher

Cambridge: Cambridge University Press

Journal title

Journal of clinical and translational science, 2024-04, Vol.8 (s1), p.144-144

Language

English

Formats

Publication information

Publisher

Cambridge: Cambridge University Press

More information

Scope and Contents

Contents

OBJECTIVES/GOALS: Untargeted metabolomics platforms are powerful biomarker discovery tools. However, the absence of uniform study design, data analysis, and reporting standards limits translation of this research into the clinical lab. The goal was to critically appraise existing untargeted metabolomics platforms that analyzed inborn errors of meta...

Alternative Titles

Full title

488 From discovery to the clinical laboratory: a methodological appraisal of untargeted metabolomics platforms to characterize inborn errors of metabolism

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a1c4844a321340c3986bae0e83fe5945

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a1c4844a321340c3986bae0e83fe5945

Other Identifiers

ISSN

2059-8661

E-ISSN

2059-8661

DOI

10.1017/cts.2024.414

How to access this item